Arké SMO S.A. de C.V.

México 06700

1 studies enrolling now · 1 studies all time

What they study most

Non-small Cell Lung Cancer

Studies at this site

• A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1% — Recruiting now